Biosimilar growth and the impact on U.S. health care

December 6, 2021

Fortune

Related news

In the news

April 16, 2024

Prime Study Finds Lower Adherence, Higher Costs for Weight Loss Drugs | AMCP 2024

Managed Healthcare Executive: Use of GLP-1 drugs and weight-loss care management programs need to focus on adherence and persistency for better health outcomes, suggests Prime Therapeutics/MagellanRx Management poster at AMCP 2024

In the news

April 3, 2024

A conversation with Marci J. Chodroff, M.D.

Managed Healthcare Executive (page 9)